INTRODUCTION
============

In the 1980s, the field of cellular signal transduction underwent total metamorphosis. Until then only two major paradigms of signal transduction, that of cyclic AMP and that of IP~3~ (inositol triphosphate) were known and were used to explain cellular signaling mechanisms and the second messenger concepts. Each of these two paradigms constituted an assemblage of three components -- receptor, GTP binding protein, and the transducer catalyst -- necessary for signal transduction. The astonishing discovery of a novel membrane protein that was simultaneously a receptor of a hormone and the transducer of its signal added a new dimension to our understanding of cellular signal transduction. The hormone was the newly described atrial natriuretic factor (ANF; [@B15]) and the membrane protein was both its receptor and guanylate cyclase enzyme, termed therefore atrial natriuretic factor receptor guanylate cyclase (ANF-RGC; [@B62]; [@B96]; [@B97]; [@B120]; [@B79]). Other terms to describe the protein are GC-A and NPR-A. ANF-RGC responded to ANF binding with accelerated synthesis of its second messenger cyclic GMP. The novelty of the system was 2-fold; first, a single protein, ANF-RGC, which contained both the ability to recognize the ANF hormonal signal and the activity to translate the hormonal information into the production of its second messenger, cyclic GMP was identified; and second, cyclic GMP was recognized as *bona fide* hormonal second messenger. Until then, the majority of laboratories forcefully denied the hormonal second messenger role of cyclic GMP (reviewed in [@B110], [@B111]).

The concept that ANF-RGC is indeed both hormone receptor and a catalyst was further supported by cloning studies ([@B10]; [@B70]; [@B94]; [@B22]; [@B74]). Homology cloning made possible finding other receptor membrane guanylate cyclases: C-type natriuretic peptide receptor guanylate cyclase, CNP-RGC (also known as GC-B; [@B7]; [@B108]; [@B24]) and heat-stable enterotoxin (also guanylin and uroguanylin) receptor guanylate cyclase, STa-RGC (GC-C; [@B107]; [@B16]; [@B119]; [@B46]; [@B54]). Identification of these three structurally and functionally related membrane guanylate cyclases that were receptors for hormonally active peptides resulted in a notion that all membrane guanylate cyclases, even those still to be discovered, were receptors for specific extracellular ligands.

The notion was short-lived, however. The next four, in chronological order, identified membrane guanylate cyclases: the rod outer segment guanylate cyclases, ROS-GC1 (also known as RetGC1 or GC-E; [@B57]; [@B118]; [@B45]) and ROS-GC2 (RetGC2 or GC-F; [@B71]; [@B135]; [@B44]), the olfactory neuroepithelium guanylate cyclase, ONE-GC (also termed as GC-D) ([@B42]; [@B27]) and GC-G ([@B109]), did not respond with increased activity to any extracellular ligand. They were therefore branded as "orphan receptors" ([@B42]; [@B135]; [@B130]; [@B109]).

ROS-GC1 and ROS-GC2 were not orphan RGC, however. Biochemical and physiological findings began to reveal that regulation of their catalytic activities is specific to their physiological function which is to return the illuminated photoreceptors to the dark, resting state. The illumination leads to activation of cyclic GMP phosphodiesterase, depletion of cyclic GMP, closure of the cyclic GMP gated (CNG) channels, and lowering the free Ca^2+^ concentration (reviewed in [@B104]; [@B58]). The ROS-GCs' task is to restore the dark-level of cyclic GMP allowing opening of the CNG channels and increase of Ca^2+^ influx. Ca^2+^ concentration, thus, determines the activity of ROS-GCs but it occurs in an indirect way. Guanylate cyclase activating proteins (GCAPs) sense the post-illumination fall in Ca^2+^ and stimulate ROS-GCs to resynthesize cyclic GMP at a faster rate (reviewed in [@B17]; [@B58]). In this cyclic GMP-Ca^2+^ feedback mechanism, ROS-GCs do not respond to an extracellular ligand but to their intracellular Ca^2+^ sensing ligands, the GCAPs ([@B92]; [@B18]; [@B26]).

Soon thereafter the evidence began to emerge, primarily from our laboratory, that GCAPs are not the only Ca^2+^ sensing modulators of ROS-GC activity. While increasing Ca^2+^ concentrations inhibit ROS-GCs activity through GCAPs, two other Ca^2+^ sensors, S100B, and neurocalcin δ (NCδ) stimulate ROS-GC1 in a Ca^2+^-dependent fashion ([@B103]; [@B25]; [@B76]; [@B60]). The Ca^2+^-dependent S100B-mediated activation of ROS-GC operates in cones including their outer segments and pedicles ([@B131]). Its role in photo- and visual transductions remains to be established, but existing data indicate its involvement in transmission of the visual signal from cone ON-bipolar cells ([@B131]). Ca^2+^ signaling of ROS-GC activity mediated by NCδ is operative in retinal ganglion cells ([@B61]) but its linkage with the visual transduction is not clear yet.

Similar, but with additional twists, regulation of ONE-GC occurs in a subset of olfactory sensory neurons ([@B42]; [@B27]; [@B98]). The cyclase was initially classified as a member of the Ca^2+^ modulated subfamily ([@B27]). Its activity is modulated in a Ca^2+^-dependent fashion by NCδ ([@B27], [@B21]) and by GCAP1 ([@B29], [@B30]; [@B98]). Remarkably, the Ca^2+^-GCAP1 pattern of ONE-GC modulation is opposite to that of ROS-GC modulation. Sensing increasing concentrations of Ca^2+^ GCAP1 stimulates ONE-GC while it inhibits ROS-GC ([@B29], [@B30]).

After the Ca^2+^-dependent modulation of ONE-GC activity was demonstrated, an extracellular ligand of the cyclase was found. The ligand was the odorant uroguanylin ([@B68]; [@B35]; reviewed in [@B112]; [@B138]). Hence, ONE-GC responds to both extracellular (uroguanylin) and intracellular Ca^2+^ signals. At this point a new, two-step "cross-talk" odorant transduction model was proposed ([@B36]). In "step 1," the odorant uroguanylin interacts with the receptor domain of ONE-GC, causing its minimal activation. The cyclic GMP generated in response to uroguanylin signal opens a few of the CNG3 channels leading to some increase in \[Ca^2+^\]~i~ in the odorant receptor cell. In "step 2," the membrane bound NCδ and GCAP1 sense the increase in \[Ca^2+^\]~i~ and in their Ca^2+^-bound states fully activate ONE-GC triggering maximal influx of Ca^2+^and depolarization of the olfactory receptor cell membrane.

The odorant receptor ONE-GC linkage with the intracellular free Ca^2+^ signals brought forth a question whether this cyclase is a unique case of dually regulated membrane guanylate cyclase. Latest studies from our laboratory demonstrate that it is not. The nascent member of the hormone receptor subfamily, the ANF-RGC, is also responsive to Ca^2+^ ([@B30],[@B31]) and NCδ is the sensor protein which communicates the Ca^2+^ signal to ANF-RGC and in the Ca^2+^-bound state, activates ANF-RGC activity. The two modes of ANF-RGC activation, hormonal and Ca^2+^-dependent, engage their specific and independent pathways of transmitting the stimulatory signals to the catalytic domain. The end-product, however, is common, the second messenger cyclic GMP. Because of the individual signaling mechanisms involved in Ca^2+^ and hormonal signaling their net effects are multiplicative. Hence, in terms of the original sub-classification, the present day knowledge is that at least two cyclases, ANF-RGC and ONE-GC, are hybrids sensing both hormonal and Ca^2+^ signals.

The last cloned membrane guanylate cyclase was GC-G. Until today, the information of its function is very scarce. It was suggested that the mouse form of GC-G is selectively expressed in the sperm and may be involved in the process of capacitation ([@B59]). Other reports suggest that the cyclase is expressed in Grueneberg ganglion olfactory subsystem where it is responding to CO~2~ ([@B8]) or to cool ambient temperature indicating its role in thermo-sensation ([@B73]).

The following discussion is exclusively devoted to the ANF-RGC. It was the first template model, which established that cyclic GMP is a *bona fide* hormonal second messenger. The ongoing studies define the second ANF-RGC transduction model, Ca^2+^-modulated signaling. It makes ANF-RGC a bimodal switch, hormonal and Ca^2+^. An additional significant part of the review is coverage of the manner in which these two models have now begun to explain the biochemical principles of cardiovascular, renal and endocrine homeostasis with special emphasis on blood pressure regulation.

HORMONAL SIGNALING OF ANF-RGC ACTIVATION
========================================

BINDING OF LIGAND-HORMONE ANF
-----------------------------

Although intuitively expected, the first experimental evidence that the ANF binding site in ANF-RGC is located within the extracellular domain came first from the site-directed and deletion mutagenesis studies. A mutant ANF-RGC was cloned from rat adrenal cDNA library ([@B22]) and termed GCα. Its sequence differed from ANF-RGC by two amino acid substitutions Q^338^ → H and L^364^ → P which resulted from single nucleotide mutations, CAG → CAC and CTG → CCG, respectively. Expressed in heterologous system of COS cells, GCα was properly located in the plasma membrane and exhibited basal guanylate cyclase activity; it however, neither bound nor responded to ANF or other natriuretic peptides ([@B22]). These results demonstrated that the two amino acid substitutions exclusively abolished binding of ANF and therefore ANF signaling of the cyclase activity. Restoration by site-directed mutagenesis, glutamine at position 338 and leucine at position 364, reinstated ANF binding and ANF-dependent stimulation of the cyclase.

The site of ANF binding was further systematically analyzed ([@B77], [@B78]; [@B48]; [@B81]). By cross-linking and proteinase digestion it was determined that the amino terminus of ANF is in contact with the region M^173^-F^188^ of ANF-RGC, and the C-terminus, with D^191^-R^198^ region. The fact that the identified contact sites were very close to each other was interpreted that the N- and C- termini of ANF interface distinct subunits of ANF-RGC homodimer. Importantly, it also implied that one ANF-RGC dimer binds one molecule of ANF.

Details of ANF binding to the ANF-RGC extracellular domain were unraveled by analyses of the extracellular domain of ANF-RGC co-crystallized with ANF ([@B88], [@B87]). These analyses revealed that (1) the extracellular domain of ANF-RGC exists as a dimer in the head-to-head configuration; (2) one ANF-RGC dimer binds one molecule of ANF (2:1 complex); (3) the binding site in one monomer differs from that in the other - one monomer binds the N-terminal part of ANF and the other binds C-terminal part; (4) there is no preference in ANF binding to a specific monomer of the extracellular domain; bound ANF occurs in two alternate orientations of equal occurrence; (5) the membrane-distal portion of the extracellular domain contains chloride ion necessary for ANF binding.

TRANSMEMBRANE MIGRATION OF THE ANF BINDING SIGNAL
-------------------------------------------------

With the exception of enterotoxin RGC, all membrane guanylate cyclases contain a hinge region juxtaposed to the N-terminal side of the transmembrane domain. This region contains two conserved cysteine residues separated from each other by 6--8 residues. In ANF-RGC these residues are Cys^423^ and Cys^432^ and were indicated as a critical structural motif in ANF signaling ([@B50]; [@B65]; [@B84]). There was however no consensus on the mechanism of its operation. Based on results with intact cells transfected with ANF-RGC cDNA it was proposed that the cysteines are involved in dimerization through the formation of an inter-chain S-S bridge ([@B50]; [@B64]) or, that they form an intra-chain disulfide bridge ([@B50]; [@B84]). Analyses of guanylate cyclase activity in isolated membranes of COS cell expressing C^423^S, C^432^S, and C^423^S, C^432^S mutants ([@B34]) allowed to conclude that both C^423^ and C^432^ residues independently and equally control the catalytic activity of ANF-RGC and that activation of ANF-RGC does not involve interchain-disulfide bond formation. In the basal state, the disulfide motif keeps the ANF-RGC in its repressed catalytic state and ANF/ATP signaling brings it to the fully active state ([@B34]).

A model of hormone-induced rotation has been proposed to explain how the extracellular signal is transmitted through the hinge region to the intracellular domain of ANF-RGC ([@B87]; [@B82]). Binding of ANF causes a twist motion of both ANF-RGC monomers centered on a support point close to the bound ANF. This twist motion translocates the juxtamembrane domains of both monomers with only minimal change in the distance between them. This movement constitutes a signal, which is transmitted through the transmembrane domain. Rotation of the transmembrane domain by 40 degrees occurs in response to ANF binding ([@B95]).

PASSAGE OF THE ANF SIGNAL THROUGH THE INTRACELLULAR DOMAIN
----------------------------------------------------------

### ANF signaling requires ATP

Early studies, before the biochemical characterization of ANF-RGC, demonstrated that activation by ANF is significantly amplified by ATP in the guanylate cyclase activation ([@B63]; [@B12]; [@B6]; [@B67]; reviewed in [@B110]; [@B37]). Subsequently, it was demonstrated that ATP is obligatory for ANF-dependent activation of ANF-RGC ([@B11]; [@B75]; [@B43]; [@B134]; reviewed in [@B37]). Because the ATP effect was mimicked by its non-hydrolyzable analogs, ATPγS and AMP-PNP, it was suggested that ATP acts as an allosteric regulator ([@B11]; [@B75]; [@B43]; [@B134]; reviewed in [@B37]). Shortly thereafter it was shown that ATP is also obligatory for the CNP-dependent stimulation of CNP-RGC ([@B23],[@B24]). Thus, it appears that the requirement of ATP is a common attribute of natriuretic peptide RGC signaling.

Studies with ANF-RGC deletion mutants revealed that the ATP regulated region resides in the intracellular portion of ANF-RGC between the transmembrane and the C-terminal catalytic domain ([@B9]; [@B43]). This region was named the kinase homology (or kinase-like domain; KHD or K-LD) because of its sequence similarity with the corresponding domains of tyrosine kinases ([@B10]; [@B9]; [@B22]). A model for the ATP function was proposed that "binding of ANP to the extracellular domain of its receptor initiates a conformational change in the protein K-LD, resulting in de-repression of guanylate cyclase activity" ([@B9]). The central idea behind the model was that KHD in native ANF-RGC suppresses the catalytic module activity; ANF functions by relieving this suppression. Study from our group using two KHD deletion mutants, Δ506--677 and Δ555--762, negated this model and proposed an alternative one where ATP via ATP regulated module (ARM) potentiates the hormonal signal "(1) the signal is caused by the binding of the hormone to the receptor site; (2) there is a transmembrane migration of the signal; (3) the signal is potentiated by ATP at ARM; and (4) the amplified signal is finally transduced at the catalytic site" ([@B43]).

### ATP allosteric effect and the ARM domain

Within the KHD ANF-RGC contains a sequence, G^503^-X-G^505^-X-X-X-G^509^ ([@B43]) which is a modified form of the protein kinases' nucleotide-binding consensus sequence G-X-G-X-X-G necessary for kinase activity ([@B132]; [@B47]; [@B2]). This motif was probed for its significance in ATP function in ANF signaling. Through analyses of a series of deletion and point mutants it was determined that the G^503^-X-G^505^-X-X-X-G^509^ motif is critical for the ATP function ([@B43]; [@B23]; [@B33]; reviewed in [@B110]; [@B37]). Although it is not involved in ATP binding it maintains the steric arrangements to fit the ATP molecule. For this reason, the motif has been named ARM ([@B43]) and the KHD, where the ARM resides, was termed the ARM domain ([@B28]; [@B116]). To get an insight into the mechanism of ATP function, the structure of the ARM domain was simulated through computer-assisted homology based modeling ([@B28]; [@B116]; PDB ID 1T53). The basic structural features of the model have been experimentally validated through point mutation/expression studies ([@B28]; [@B116]; reviewed in [@B110]; [@B37]).

***Spatial determinants of the ARM domain***. The domain comprises amino acid residues 496--771, which are arranged into two lobes: the smaller, N-terminal (91 aa residues: 496--586), and the larger, C-terminal (185 aa residues: 587--771; [@B28]). Four antiparallel β strands and one α helix form the smaller lobe; the larger lobe is predominantly helical, composed of eight α-helices and two β strands ([@B28]; [@B116]). The ARM motif, G^503^-X-G^505^-X-X-X-G^509^, is located within the smaller lobe.

***The ATP-binding pocket***. In order to identify the ARM domain residues potentially involved in ATP binding the model of this domain in its ATP-bound form was analyzed ([@B37]). A radius of 4 Å from the ATP molecule was chosen as the limiting distance for the electrostatic, hydrogen or van der Waals' interactions. Two sets of residues were identified (Figure 4 in reference [@B37]): (1) those forming the floor of the ATP binding pocket; (2) those surrounding ATP molecule. The residues in the first set are: G^503^, R^504^, G^505^, S^506^, N^507^, Y^508^, and G^509^. These residues have no direct chemical interaction with ATP; they, however, provide necessary space to accommodate the ATP molecule. The residues in the second set surround the individual components of ATP, the adenine ring, the ribose ring and the triphosphate moiety. The adenine ring is surrounded by L^511^, T^513^, T^514^, E^515^, Q^517^, A^533^, T^580^, E^581^, C^583^, V^635^, and T^645^ and L^511^, T^513^, and C^583^ are within a distance shorter than 3 Å.

G^503^, L^511^, T^513^, T^514^, G^580^, S^587^, D^590^surround the ribose ring with L^511^ and T^514^ located within 2.5 Å radius from the ribose. The phosphate groups are surrounded by R^504^, G^505^, L^511^, K^535^, N^633^, D^646^, and K^535^ is the nearest residue (2.6 Å) forming a hydrogen bond with the phosphate and has been shown to be critical for ATP regulation of ANF-dependent ANF-RGC activity; D^646^ interacts with the triphosphate group of ATP through the formation of a coordinate bond with the metal ion Mg^2+^.

***Interaction of ATP with the ARM domain***. Kinetics of ATP binding to the ARM domain was determined through SPR spectroscopy ([@B4]). AMP-PNP, the non-hydrolyzable analog of ATP was used for the binding studies. Half-maximal binding (EC~50~) occurred when the concentration of AMP-PNP was \~0.2 mM and the calculated *K*~D~ value was 0.21 mM. Similar results (EC~50~ value of 0.15 mM and *K*~D~ of 0.13 mM) were obtained when 8-azido-ATP was used.

The model-predicted ATP binding pocket (*vide supra*) was authenticated experimentally by cross-linking of the purified isolated ARM domain protein with 8-azido-ATP, trypsin digestion of the cross-linked product and sequencing of the resulting peptides ([@B4]). Three peptides were found to be photoaffinity modified. The longest modified peptide was identified as G^614^MLFLHNG-AICSHGNLKSSNCVVDGR^639^and the shortest as S^631^SNC^634^V^635^VDGR. In all three peptides Cys^634^was modified indicating that this residue was the closest to the azido group. The G^614^--R^639^ fragment contains six ATP-binding pocket-predicted residues ([@B37]): S^625^, K^630^, S^631^, S^632^, N^633^, and V^635^; and the shortest S^631^--R^639^ fragment contains three residues: S^631^, N^633^, and V^635^([@B37]). The refined ARM model ([@B37]) predicts that V^635^ is within a 4 Å radius from the adenine ring; cross-linking of the neighboring residue to C^634^ validates that these residues are indeed the closest to the C-8 of the adenine ring.

***ATP binding dependent changes in the ARM domain.*** If ATP binding to the ARM domain were to serve signaling purposes, it should induce structural changes that ultimately would signal activation of the catalytic domain. Comparative analyses of the ARM domain models in the apo and ATP-bound states identified such changes. They involve rotations of the β strands within the smaller lobe as well as movements of the β strands and α helices in the larger lobe ([@B28]; [@B116]; reviewed in [@B37]). Consequences of two such changes appear to be of particular importance: first, of the β1, β2 strands in the smaller lobe, and the second, of the EF and F helices in the larger lobe.

The β1 and β2 strands and the loop connecting them encompasses the G^503^-X-G^505^-X-X-X-G^509^ motif ([@B28]; [@B116]; reviewed in [@B37]), which is meshed in and flanked by six phosphorylation sites, S^497^, T^500^, S^502^, S^506^, S^510^, T^513^ ([@B99], [@B101]). The present consensus is that "phosphorylation of KHD is absolutely required for hormone-dependent activation of NPR-A" ([@B99],[@B100], [@B102]). In this concept, hypothetical protein kinase and protein phosphatase co-exist with ANF-RGC ([@B41]). Until now, however, neither the kinase nor the phosphatase has been identified.

Comparison of the ATP-free and ATP-bound ARM domain models allows explaining how ATP binding makes it possible for the serine and threonine residues to undergo phosphorylation. After ATP binds to the ARM domain, the β1, β2 strands, and the loop between them shift by \~3--4 Å and rotate by \~15° ([@B28]; [@B116]; reviewed in [@B37]). This movement triggers reorientation of the serine and threonine residues (**Figure [1](#F1){ref-type="fig"}**, red colored residues) causing the side chains and the OH groups of T^500^, S^502^, S^506^, and T^513^ becoming directed toward the protein surface (**Figure [1](#F1){ref-type="fig"}**, compare the positions of the cyan- and red-colored OH groups). The change in the positions of the side chains is most drastic for the S^502^ and S^506^ residues. Although upon ATP binding there is no toward the surface reorientation of the S^497^ and S^510^ OH groups, the entire residues are shifted toward the surface (**Figure [1](#F1){ref-type="fig"}**). This structural rearrangement permits the hypothetical protein kinase to access the side chains of the residues and transfer the phosphate group ([@B38]).

![**ATP binding to the ARM domain affects the conformation of the six phosphorylable residues.** The conformation of the six phosphorylated residues is shown before (cyan) and after (red) ATP binding. The ATP molecule is shown in green. The positions of the OH groups are indicated by cyan and red balls (reproduced with permission from ref. [@B38]).](fnmol-07-00017-g001){#F1}

Another important result of ATP binding on the dynamics within the ARM domain is the translocation within the larger lobe of two helices, EF and F. Their movement was characterized by analyzing the ATP-dependent changes in the fluorescence intensity and wavelength of two tryptophan residues W^601^ and W^669^ ([@B20]). Both residues reside in the larger lobe of the ARM domain, outside the ATP-binding pocket. The W^601^ residue is a part of the helix E structure ([@B28], [@B37]), its side-chain is oriented toward the protein surface, and it is flanked by several hydrophobic residues, F^640^, L^607^, S^606^, and S^596^ (**Figure [2A](#F2){ref-type="fig"}**). These structural features define the fluorescence λ~max~ of W^601^ at 332 nm. W^669^ residue is located at the end of a loop connecting β8 strand and EF helix ([@B20]); it is a part of a conserved hydrophobic motif, ^669^WTAPELL^675^. The side chain of W^669^ is flanked by the polar residues: E^699^, S^631^, K^667^, K^630^, and L^696^ (**Figure [2B](#F2){ref-type="fig"}**). This environment causes red shifts in the fluorescence λ~max~ of W^669^ to 345 nm.

![**(A)** Amino acid residues surrounding W^601^ and **(B)** amino acid residues surrounding W^669^ within the ARM domain. Amino acid residues depicted in red are located within a 4 Å sphere from the respective tryptophan residue (green). **(C)**Conformational changes within the ^669^WTAPELL^675^ motif induced by ATP binding to the ARM domain. The backbone structure of the ATP-bound ARM domain is shown in cyan and the ATP molecule is in green. The ^669^WTAPELL^675^ motif is shown in magenta color. Apo structure of the ARM domain was superimposed on the ATP-bound form to assess the relative, ATP binding induced, conformational changes. For clarity, only the ^669^WTAPELL^675^ motif (shown in red) of the apo-enzyme is visible. ATP binding results in a more compact structure of the ARM domain: the W^669^ side chain moves toward the ATP binding pocket while the side chains of T^670^, E^673^, L^674^, and L^675^ move toward the protein surface \[compare the orientation of side chain of these amino acid residues before (in red) and after (in magenta) ATP binding; fonts for W^669^ and L^675^ residues are increased for better visibility\]. This movement changes the surface properties of the ARM domain. The movement toward the surface of the protein is poised to facilitate interaction of this amino acid stretch with subsequent transduction motif, possibly within the catalytic domain, propagation of the ANF/ATP binding signal and activation of the catalytic domain (reproduced with permission from ref. [@B20]).](fnmol-07-00017-g002){#F2}

Superimposition of the ATP-free and the ATP-bound forms indicates that ATP binding induces contraction of the entire ARM domain and affects the orientation and environment of W^669^. The contraction results in shortening of the distance between W^669^and the ATP binding pocket (**Figure [2C](#F2){ref-type="fig"}**). ATP binding also causes reorientation of the W^669^ side chain. It turns and becomes more shielded by the surrounding amino acids. Turning of the W^669^ side chain pushes the remainder of the motif, ^670^TAPELL^675^, to the surface resulting in its exposure. In general, the movement of a hydrophobic motif toward the surface of the protein indicates its readiness for interaction. For the ^669^WTAPELL^675^ motif it was proposed that it interacts with subsequent transduction motif, possibly within the catalytic domain, propagates the ANF/ATP binding signal and activates the catalytic domain ([@B20]).

Based on the studies narrated above a model for ANF/ATP signaling of ANF-RGC activity was proposed: The ANF signal originates by the binding of one molecule of ANF to the extracellular dimer domain of ANF-RGC ([@B87], [@B86]). The binding modifies the juxtamembrane region where the disulfide ^423^Cys-Cys^432^ structural motif is a key element in this modification ([@B87], [@B86]; [@B34]). The signal twists the transmembrane domain ([@B95]), induces a structural change in the ARM domain, and prepares it for the ATP activation. ARM domain binds ATP to its pocket what leads to a cascade of temporal and spatial changes ([@B28]; [@B116]; reviewed in [@B37]). They result in (1) exposure of the hydrophobic ^669^WTAPELL^675^ motif which directly (or indirectly) interacts with the catalytic domain causing its partial activation; and (2) exposure and phosphorylation of six serine, threonine residues and full activation of ANF-RGC. Concomitantly, phosphorylation converts ATP binding site from the high to low affinity, ATP dissociates and ANF-RGC returns to its ground state ([@B38]).

CATALYTIC DOMAIN
----------------

When more then 20 years ago an ANF RGC was purified to homogeneity and shown to contain the ANF binding and cyclic GMP forming activities on the same protein chain, the authors proposed a topological model for the transmembrane receptor enzyme in which the receptor part was extracellular and the cyclase catalytic domain was intracellular ([@B113],[@B114]). The cloning studies confirmed this prediction. Alignment of the deduced amino acid sequences of the cloned guanylate cyclases indicated that the catalytic domain is located at the C-terminus of ANF-RGC and comprises 239 amino acid residues ([@B10]; [@B22]). This prediction was tested experimentally ([@B122]; [@B123]). The carboxy terminal 293 amino acids fragment of ANF-RGC was expressed as a soluble protein and shown to exhibit guanylate cyclase activity. These results were in agreement with studies that determined through radiation inactivation experiments that the ANF-RGC fragment containing cyclase activity has a molecular weight of 32 ± 8 kDa ([@B124]). Further studies identified several residues within this region that appeared to be critical for the guanylate cyclase activity: L^817^ ([@B80]), D^877^, K^887^, D^893^, G^900^, H^909^, R^940^, and H^944^ ([@B121]). Their individual mutations to Ala resulted in ANF-RGC mutants without detectable guanylate cyclase activity. In contrast to these residues, mutation of E^974^ to Ala resulted in a hyperactive ANF-RGC mutant ([@B129]). Based on these results it was concluded that the indicated residues are located within or close to the catalytic center or are critical for the proper folding of the catalytic center.

In the absence of a crystal structure of any membrane guanylate cyclase catalytic domain a model of the catalytic center of retGC-1, a mammalian membrane guanylate cyclase expressed in the retina, also known as ROS-GC1 was proposed ([@B69]). The model was built based on homology with the catalytic center of the adenylate cyclase. The modeling studies allowed identification of the critical residues constituting the catalytic core. Because the catalytic domains of all membrane guanylate cyclases are highly conserved (\>95% of sequence identity), by homology substitution, the critical residues of the ANF-RGC catalytic center have been identified and they are described below.

The catalytic center is homodimeric. There are two GTP binding sites. Each GTP molecule interacts with both monomers. In the following description of the ANF-RGC catalytic center the monomers are labeled "A" and "B" and the location of each residue within a monomer A or B is indicated. Numbering of amino acids is according to the mature protein ([@B22]). R^959^(B) and C^961^(B) interact with guanine's O6; second NH~2~ group of R^959^(B) interacts with guanine's N1; the carboxy group of E^889^(B) interacts with R^959^(B) and through it with N1; G^964^(B) interacts with N7; T^854^(A), D^893^(A) and N^968^(B) form hydrogen bonds with ribose's OH (3′) group; R^972^(B binds α phosphate group; R^940^(A) binds β phosphate group; E^974^(A) through Mg^2+^ interacts with β phosphate group; and S^971^(A) binds γ phosphate group. Specificity toward GTP is determined by E^889^ and C^961^ of ANF-RGC. This conclusion is drawn based on studies showing that in ROS-GC1 mutation of the corresponding E to K and C to D converts guanylate cyclase activity into adenylate cyclase activity ([@B125]).

### Mechanism of ANF-RGC activation -- the role of the ^669^WTAPELL^675^ motif

An important feature of the model of ANF/ATP-dependent activation of ANF-RGC is the relay function of the ^669^WTAPELL^675^ motif. It switches between the ATP-bound ARM domain and activates the catalytic domain. It was proposed that this motif interacts with and signals the antiparallel homo-dimer of the catalytic domain to undergo conformational changes and form a functional catalytic center ([@B20]). The exact site within the catalytic domain which is targeted by the ^669^WTAPELL^675^ motif remains to be determined. Preliminary scanning experiments, however, suggest that the site may be located close to the E^889^, a residue critical for cyclase specificity toward GTP ([@B125]).

If the elements of the model are correct and the ^669^WTAPELL^675^ motif is a switch, its deletion from the ANF-RGC should lead to a protein which binds ANF and ATP but is not able to respond to them with increased synthesis of cyclic GMP. This assumption was tested experimentally. An ANF-RGC mutant was created in which the ^669^WTAPELL^675^ motif was deleted by mutagenesis. Wild type ANF-RGC and the mutant were expressed individually in COS cells and their membranes were analyzed (1) by Western blot to determine the proteins' levels of expression; (2) for basal guanylate cyclase activity; (3) for ANF binding; and (4) for K~M~ for the substrate GTP. The results demonstrated that (1) the wild type ANF-RGC and the ^669^WTAPELL^675^ deletion mutant were expressed to the same level as determined by Western blot; (2) the basal cyclase activity of the mutant, 20 pmol cGMP min^-1^ (mg protein)^-1^, was virtually identical to that of the wild type ANF-RGC, 21 pmol cGMP min^-1^ (mg protein) ^-1^; (3) their receptor activities were equal with the respective specific binding values of 9.7 ± 0.6 and 10.1 ± 0.9 pmol \[^125^I\]ANF/mg protein and (4) the K~M~ values for the substrate GTP, 614 μM for the wild type and 608 μM for the mutant protein were identical. Thus, the basal integrity of the protein remained intact despite the deletion ([@B20]).

When the mutant was exposed to increasing concentrations of ANF and ATP its cyclase activity remained practically unchanged whereas under identical conditions wild type ANF-RGC was stimulated over 6-fold ([@B20], [@B32]) demonstrating that in line with the original expectations the catalytic domain does not increase cyclic GMP synthesis in the presence of ANF/ATP. This type of outcome could only be observed if the mutant protein did not bind ANF and/or ATP or the catalytic domain lost its cyclase ability. Both of these possibilities were put to rest as the mutant and the wild type cyclase did not differ in ANF and ATP binding nor in enzymatic activity (*vide supra* and ref. [@B20]). Therefore the only explanation for the unchanged level of cyclic GMP synthesis is that the ^669^WTAPELL^675^ deletion mutant is not able to respond to ANF and ATP. This leads to just one logical conclusion that in the absence of the ^669^WTAPELL^675^ motif the ANF/ATP binding information is not transmitted to the catalytic domain. Thus, the ^669^WTAPELL^675^ motif is the critical transmitter of the ATP-potentiated ANF signal to the catalytic domain where it is translated into generation of cyclic GMP.

Ca^2+^ SIGNALING OF ANF-RGC ACTIVITY
====================================

NEURONAL CALCIUM SENSOR NEUROCALCIN δ
-------------------------------------

Neurocalcin δ belongs to a distinct subfamily of neuronal calcium sensor proteins (NCS) together with visinin-like proteins (VILIPs) and hippocalcin. They all are acylated at the N-terminus by myristic acid and undergo a classical calcium-myristoyl switch ([@B66]), e.g., they bury the myristoyl group in a hydrophobic pocket in Ca^2+-^free form and expose it in Ca^2+^-bound form, as first observed and described for recoverin ([@B137]). Exposure of myristoyl group enables the protein association with the cell membrane. However, once it binds, in a Ca^2+^-dependent fashion, to the membrane phospholipids, even after removing Ca^2+^ by the addition of EGTA part of it remains membrane bound ([@B61]). Although NCδ is primarily expressed in neuronal tissues, its expression in the periphery is also observed.

Functionally, NCδ has been linked to receptor endocytosis through interaction with α- and β-clathrin and β-adaptin ([@B52]), trafficking and membrane delivery of glutamate receptors of the kainate type ([@B13]), and due to its Ca^2+^-dependent affinity for S100B protein and tubulin β-chain ([@B89]), with microtubule assembly ([@B51]). In the sensory and sensory-linked neurons, the presence of NCδ has been found in the inner plexiform layer of the retina, e.g., in the amacrine and ganglion cells ([@B61]), olfactory sensory neurons ([@B27], [@B21]) and recently, it has been identified in type II cells of mouse circumvallate taste papillae, indicating its possible role in gustatory transduction ([@B105]).

A relatively newly identified function of NCδ is its Ca^2+^-dependent modulation of the activities of membrane guanylate cyclases ROS-GC1 in the retina and ONE-GC, in the olfactory neuroepithelium ([@B28], [@B21]; [@B61]). In these tissues NCδ co-localizes with its respective target cyclases. The exact physiological significance of the ROS-GC1- NCδ signaling system in the retinal neurons is not known yet. It can be, however, safely stated that the pathway is not present in the rod and cone outer segments, thus is not linked with the phototransduction machinery. The system has been localized to the lower strata of the inner plexiform layer and to a subpopulation of ganglion cells ([@B61]).

In the olfactory neuroepithelium NCδ serves as a Ca^2+^ sensor component of the two-step odorant uroguanylin signaling machinery. This signaling mechanism was proposed to be initiated by uroguanylin interaction with the extracellular receptor domain of ONE-GC ([@B68]; [@B35]; reviewed in [@B138]; [@B112]). This interaction leads to partial activation of ONE-GC, generation of small amount of cyclic GMP, partial opening of cyclic GMP-gated channel and influx of Ca^2+^ into the olfactory receptor neuron. In the next step, Ca^2+^ binds to NCδ which, then fully activates ONE-GC ([@B36]).

FREE CA^2+^ SIGNALS ANF-RGC ACTIVATION
--------------------------------------

In the course of mapping the NCδ targeted site on ROS-GC1 to which it binds and transmits the Ca^2+^ signal to the catalytic domain for signal translation into the generation of cyclic GMP, our group made a remarkable observation that NCδ binds directly to the catalytic domain and, thereby, activates ROS-GC1 ([@B126]). Protein database comparison shows sequence conservation of the catalytic domain in the membrane guanylate cyclase family hinting at a possibility that other membrane guanylate cyclases might be activated by Ca^2+^ via NCδ as well. To test this possibility, ANF-RGC membrane guanylate cyclase, for which the only established signal transduction mechanism was through ANF/ATP (*vide supra*), was chosen. And indeed, in a recombinant system, myristoylated NCδ stimulated ANF-RGC activity in a dose- and Ca^2+^-dependent manner; 0.5 μM Ca^2+^ and 0.5 μM NCδ triggered half-maximal activation of ANF-RGC ([@B30],[@B31]). These results for the first time demonstrated that ANF-RGC activity is dually regulated, by peptide hormones ANF and BNP, and by Ca^2+^, thus, at least *in vitro* the cyclase was deemed a bimodal signal transducer.

### Myristoylated dimeric form of neurocalcin δ is the transmitter of the Ca^2+^ signal

Since NCδ belongs to the family of NCS and myristoylation at N-terminus is a characteristic feature of a majority, but not all, of these proteins important for their cellular function, it was necessary to check whether myristoylation was required for NCδ to transmit the Ca^2+^ signal for ANF-RGC activation. Reconstitution experiments of ANF-RGC with both myristoylated and non-myristoylated NCδ showed that only the myristoylated NCδ stimulated the cyclase activity whereas the non-myristoylated form was ineffectual ([@B31]). Importantly, both forms exhibited comparable affinity for ANF-RGC. In addition to activating ANF-RGC myristoylated NCδ also lowered the cyclase's K~M~ for substrate GTP and increased its catalytic efficiency, *k*~cat~, from 6.5 ± 0.3 to 41.4 ± 0.5 pmol cyclic GMP/s.

The biochemical and homology based modeling studies indicate that the secondary structure of the functional form of all membrane guanylate cyclases is homodimeric ([@B106]; [@B69]; [@B126]). The contact points for their homo-dimeric formation reside in their extracellular domain ([@B83]) and in the intracellular domain within the highly conserved dimerization domain ([@B133]) and core catalytic core domain ([@B126]). The X-ray crystallographic studies have demonstrated that NCδ also exists as a dimer ([@B127]). Thus, it was reasonable to expect that the Ca^2+^-modulated functional unit is NCδ dimer and ANF-RGC dimer.

This expectation was validated experimentally. When monomeric and dimeric forms of myristoylated NCδ were individually tested in reconstitution experiments for their abilities to stimulate ANF-RGC catalytic activity only the dimer was effective ([@B31]). The stimulation by the monomeric form was only marginal, possibly resulting from spontaneous dimerization of the monomers when higher NCδ concentrations were used ([@B31]). Thus indeed the functional Ca^2+^ signal transduction unit is composed of one NCδ dimer and one ANF-RGC dimer.

### Neurocalcin δ targets directly the catalytic domain of ANF-RGC

The ANF-RGC fragment, aa 788--1029, encompassing the core catalytic domain, I^820^--G^1029^, was expressed as a soluble protein and tested for its basal and Ca^2+^-dependent modulated *via* NCδ activities. The protein exhibited intrinsic guanylate cyclase activity (18 ± 4 pmol cyclic GMP min^-1^ mg protein^-1^). This activity increased when Ca^2+^ and NCδ were added, and the increase was Ca^2+^ and NCδ-dose dependent ([@B31]). Interestingly, the estimated EC~50~ for NCδ was comparable to that determined for full-length ANF-RGC strongly supporting the expectation that the NCδ signaling site resides within the catalytic domain.

The NCδ targeted site on ROS-GC1 was mapped to the aa segment V^837^--L^858^. The corresponding site on ANF-RGC, ^849^DIVGFTALSAESTPMQVVTLLMQ^871^, has 70% sequence conservation in comparison with ROS-GC1. When a synthetic peptide of this sequence was used in a functional interference experiment almost complete inhibition of the NCδ-stimulated ANF-RGC activity at 200 μM with an IC~50~ value of 80 μM was observed ([@B31]). Because a scrambled peptide did not exhibit any inhibitory effect it was justified to conclude that the ANF-RGC region ^849^DIVGFTALSAESTPMQVVTLLMQ^871^ mediates NCδ-dependent Ca^2+^ stimulation of ANF-RGC activity. This region is a part of the core catalytic domain and common to the corresponding sites in other membrane guanylate cyclases^28^, it has a secondary structure of helix-loop-helix and is acidic in nature with a pI of 3.37 ([@B31]).

### The effects of ANF/ATP and Ca^2+^-neurocalcin δ signaling of ANF-RGC activity are multiplicative

To determine the liaison between ANF/ATP and Ca^2+^-NCδ signaling modes, ANF-RGC activity was analyzed first in the presence of 1 μM Ca^2+^ and 2 μM myristoylated NCδ and then with increasing concentrations, ranging from 10^-11^ M to 10^-6^ M, of ANF and constant 0.8 mM ATP. The presence of Ca^2+^ and NCδ resulted in stimulation of the cyclase activity approx. 3.5-fold above the basal activity. Addition of ANF and ATP resulted in additional 4.5-fold stimulation, demonstrating that the Ca^2+^-NCδ and ANF/ATP effects are multiplicative ([@B31]). It is noteworthy that in the absence of Ca^2+^ in the reaction mixture only the ANF/ATP-dependent stimulation of ANF-RGC activity was observed.

The preceding narration on the mechanisms involved in the hormone- or Ca^2+^-NCδ-dependent stimulation of ANF-RGC activity explains the independence and multiplicativeness of the ANF and Ca^2+^-NCδ signals in the activation of ANF-RGC. It is based on our evolving conceptual scheme whose central idea is that the functional specificity of a guanylate cyclase is determined by the structure of its modular blocks. The structural motif, ^669^WTAPELL^675^ is involved in transmitting the ANF signal to the catalytic domain ([@B20]) but it is not involved in transmitting the Ca^2+^ signal to the catalytic domain; instead the ^849^DIVGFTALSAESTPMQVVTLLMQ^871^ motif is involved ([@B31]).

PHYSIOLOGICAL VALIDATION OF THE TWO SIGNALING MECHANISMS OF THE ANF-RGC ACTIVATION
==================================================================================

The two described above signaling mechanisms of ANF-RGC activation are depicted in **Figure [3](#F3){ref-type="fig"}**. It is obvious from their description that they were developed based solely on biochemical observations. And although biochemically well-proven, they would have to be considered only hypothetical until their validity was confirmed *in vivo*. And this validation is narrated below.

![**(A)** Topography of ANF-RGC. The dashed lines on the right show the boundaries of: LS, leader sequence; ExtD, extracellular domain; TM, transmembrane domain; ICD, intracellular domain. The functional domains in ICD, their names and the aa constituting their boundaries are indicated at the left: JMD, juxtamembrane domain; ARM, the ATP regulated module; SHD-signaling helix domain; CCD-core catalytic domain. The site targeted by NCδ (encircled) is within CCD. **(B)**The signaling pathways of ANF and of NCδ are independent. The trajectory of the ANF pathway is in red dashed arrow. From the ExtD, it passes through the TM, ARM and SHD in its course to CCD. The trajectory of the NCδ pathway (in blue dashed arrow) is within the CCD. The CCD exists as an antiparallel homodimer (reproduced with permission from ref. [@B31]).](fnmol-07-00017-g003){#F3}

SIGNALING THROUGH THE ^669^WTAPELL^675^ MOTIF
---------------------------------------------

In an *in vitro* reconstituted system the ^669^WTAPELL^675^ motif is critical for the transmission of the ANF/ATP signal and activation of the ANF-RGC catalytic domain and its absence results in unresponsiveness of the mutated ANF-RGC to the signal so if the same happens *in vivo*, an animal model in which the sequence coding for the ^669^WTAPELL^675^ motif is deleted from the ANF-RGC gene should be unresponsive to ANF and therefore exhibit all physiological consequences of this unresponsiveness. Following this logic, the ^669^WTAPELL^675^ sequence was deleted in genetically altered mice ([@B32]). It is worth mentioning that up till now it is the only ANF-RGC domain-specific genetically modified animal model.

In agreement with the *in vitro* determinations, basal ANF-RGC activity in the membranes of the heart, adrenal gland and kidney, the primary tissues where ANF-RGC is expressed, was practically indistinguishable between the wild type control (ANF-RGC^669^WTAPELL^675+/+^), heterozygous (ANF-RGC^669^WTAPELL^675+/-^) and homozygous (ANF-RGC^669^WTAPELL^675-/-^) mice ([@B32]). However, the mutated cyclase expressed in these tissues did not respond to ANF/ATP stimulation. The cyclase activity in the membranes of the homozygous mice was the same when assayed in the presence of 10^-7^ M ANF and 0.8 mM ATP as when assayed in their absence. Interestingly, for the heterozygous mice, the cyclase remained responsive to ANF/ATP but the maximal achieved activity oscillated around 50% of the wild type values, clearly showing that in the heterozygous mice where the product of one ANF-RGC gene copy is of the wild type and the other, of the deletion-mutated cyclase, only the wild type ANF-RGC is responsive to ANF/ATP and the mutant is not ([@B32]). Thus, the *in vitro* activity characteristics were the mirror images of these *in vivo*.

Almost identical values of basal guanylate cyclase activity in various tissues of the ^669^WTAPELL^675^ targeted mice and their isogenic controls implied that the expression of the mutant-cyclase must not differ from the expression of the wild type cyclase. This implication was confirmed by the results of immunocytochemical analyses. Side-by-side immunostaining with immunopurified anti ANF-RGC antibody resulted in identical images of the kidneys and adrenal glands of the wild type, heterozygous and homozygous ^669^WTAPELL^675^ targeted mice. Also, visual examination of the stained sections as well as of the respective differential interference contrast images indicated that the targeting of the ^669^WTAPELL^675^ motif does not change the integrity of these tissues ([@B32]).

The main function of ANF/ANF-RGC signaling system is to regulate natriuresis, diuresis, vasodilation, and prevent cardiac and renal hypertrophy. It regulates blood volume homeostasis and blood pressure by off-setting the renin-angiotensin-aldosterone system (RAAS): inhibiting renal renin secretion and aldosterone synthesis in the adrenocortical zona glomerulosa ([@B5]; [@B3]; [@B72]; [@B91]; [@B1]; [@B117]). Therefore, elimination of ANF-RGC signaling through knocking-out either ANF-RGC or ANF gene leads to increased blood pressure, cardiac, and renal hypertrophy, fibrosis, to name some of the related pathological conditions ([@B19]; [@B55]; [@B40]; [@B14]; [@B39]; [@B93]; [@B128]). Since the ^669^WTAPELL^675^ targeted mice have partially (heterozygous) and fully (homozygous) suppressed ANF-RGC response to ANF, but the basal cyclase activity is unaffected the critical question was: does this suppression lead to increased blood pressure and other physiological alterations in the genetically modified mice?

The answer obtained was clearly "yes." In comparison with the wild type the blood pressure of the heterozygous mice increased by \~37% and of the homozygous mice by \~56%. The increase was statistically highly significant with *P* value \< 0.005 ([@B32]). It rose from 102 ± 9 mm Hg for the wild type mice to 134 ± 17 mm Hg for the heterozygous and 159 ± 11 mm Hg for the homozygous mice. These values showed that the progressive elevation of blood pressure directly correlates with the number of mutated ANF-RGC gene copies.

Because volume homeostasis and blood pressure are influenced by the mineralocorticoid hormone aldosterone secreted by the cells of the adrenocortical zona glomerulosa and the function of the ANF/ANF-RGC system is to inhibit this synthesis the obvious next question was whether the increased blood pressure in the ^669^WTAPELL^675^ targeted mice is a consequence of the inability of the mutated ANF-RGC to transduce the ANF signal and to synthesize cyclic GMP sufficient quantities to inhibit aldosterone synthesis? A hint was provided by studies on ANF-RGC knockout mice showing that these mice had increased aldosterone level ([@B136]).

The plasma aldosterone concentrations were measured in both types of genetically modified mice (hetero- and homozygous) and in their isogenic controls (wild type). The results demonstrated that, in comparison with the wild type mice, the plasma aldosterone concentration increased by approximately 40% (from 147 ± 12 to 204 ± 18 pg/ml) in the plasma of the heterozygous mice (*P* \< 0.005) and by approximately 75% (up to 256 ± 22 pg/ml) in the plasma of the homozygous mice (*P* \< 0.005) ([@B32]).

Chronic pressure overload is almost always accompanied by cardiac hypertrophy (reviewed in [@B53]). The same is observed in the ^669^WTAPELL^675^ targeted mice. The ratio of the heart weight (in mg) to whole body weight (in g) measured in 12 weeks old mice was 5.6 ± 0.3 and 6.1 ± 0.5 for the ^669^WTAPELL^675(+/-)^ and ^669^WTAPELL^675(-/-)^ mice, respectively, whereas it was 5 ± 0.3 for the wild type mice ([@B32]). However, hypertension is not the only cause of myocardial hypertrophy. Using animal models it has been shown that antihypertensive drugs do not always ameliorate cardiac hypertrophy ([@B56]) and that even without systemic hypertension cardiac hypertrophy may occur ([@B90]; [@B49]). Because deletion of the ^669^WTAPELL^675^ motif from ANF-RGC results in decreased synthesis of cyclic GMP it was hypothesized that cardiomyocytes of the ^669^WTAPELL^675^ targeted mice succumb to the insufficient quantities of cyclic GMP and normal inhibition of myocardial proliferative responses does not occur. Our ongoing studies indicate that indeed it is the case. The mice as young as 3 weeks of age (at weaning) exhibit significant cardiac hypertrophy. Which cyclic GMP-dependent signaling pathway involved in inhibition of myocardial proliferative responses is affected in these mice remains to be determined.

Taken together the biochemical and physiological evidence prove that the ^669^WTAPELL^675^ motif is critical for the ANF-RGC function as the transducer of the ANF/ATP signal.

NEUROCALCIN δ Ca^2+^-DEPENDENT SIGNALING OF ANF-RGC
---------------------------------------------------

To demonstrate that the ANF-RGC NCδ-Ca^2+^ signal transduction system is functional *in vivo* a mouse model with a disrupted NCδ gene was constructed and analyzed. Unfortunately, disruption of both copies of NCδ gene is lethal. Although it was unexpected at the time of developing the mouse line, it can be now understood in view of the results demonstrating that NCδ may be involved in spermatogenesis. Therefore, heterozygous, NCδ^+/-^, line is viable.

Because earlier studies from our laboratory and others' had shown that NCδ is expressed in the adrenocortical zona glomerulosa ([@B85]; [@B30]) and that the adrenal gland also contains functional ANF-RGC transduction system ([@B120]; [@B115]; [@B22]; [@B106]) the adrenal gland appeared to be the tissue of choice for testing whether the ANF-RGC NCδ-Ca^2+^ signal transduction system is operational and of physiological significance there.

To show that NCδ is indeed the Ca^2+^-sensor modulator of ANF-RGC in the adrenal gland the particulate fractions of the adrenal glands from wild type and NCδ^+/-^ mice and their isogenic controls (NCδ^+/+^) were tested for guanylate cyclase activity in the presence and absence of Ca^2+^. The activity in membranes isolated in the absence of Ca^2+^ was about 66 pmol cyclic GMP min^-1^ (mg protein) ^-1^ for the control and NCδ^+/-^ mice and the activity was not affected by the presence or absence of Ca^2+^ in the assay mixture. However, the activity in membranes isolated in the presence of Ca^2+^ was strongly dependent on the mice genotype and Ca^2+^ in the assay mixture. When assessed in the absence of Ca^2+^, the activity was \~70 pmol cyclic GMP min^-1^ (mg protein) ^-1^ for the weight and NCδ^+/-^ mice but when assessed in the presence of 1 μM Ca^2+^ the activity was 223 ± 20 pmol cyclic GMP min^-1^ (mg protein) ^-1^ for the wild type mice and 135 ± 10 pmol cyclic GMP min^-1^ (mg protein) ^-1^ for the NCδ^+/-^ mice. Thus, the Ca^2+^-dependent NCδ-modulated ANF-RGC signaling pathway in the mice with one copy of NCδ gene deleted (NCδ^+/-^) is functionally half as active as in the wild type mice. To further authenticate that the lowering of the Ca^2+^-dependent cyclase activity in the adrenal gland membranes of NCδ^+/-^ mice is the exclusive consequence of lower NCδ expression, 2 μM exogenous NCδ was added to the NCδ^+/+^ and NCδ^+/-^ membranes (isolated in the presence of Ca^2+^) and the cyclase activity was determined in the presence of 1 μM Ca^2+^. The cyclase activity in the NCδ^+/+^ adrenal membranes increased only minimally, from 220 to 279 ± 21 pmol cyclic GMP min^-1^ (mg protein) ^-1^ but in the NCδ^+/-^ membranes, the increase was significantly larger, from 133 to 284 ± 24 ([@B31]). Thus, the activity achieved was practically the same for both types of membranes. Hence, addition of exogenous NCδ to the NCδ^+/-^ adrenal gland membranes restores the guanylate cyclase activity and brings it to the level of activity in the NCδ^+/+^ membranes. We rationalized that the slight activity increase in the NCδ^+/+^ membranes observed upon addition of exogenous NCδ is caused by a partial loss of the native NCδ during the membrane preparation.

What is the function of this pathway in the adrenal gland? In general, the primary role of ANF-RGC in the adrenal gland is to offset the renin-angiotensin system and inhibit aldosterone synthesis, and by doing this, to lower blood pressure ([@B5]; [@B1]; [@B117]). Therefore, is the Ca^2+^-dependent ANF-RGC signal transduction machinery in the adrenal gland involved in aldosterone synthesis? Our ongoing studies indicate that indeed it is. The plasma aldosterone levels in the NCδ^+/-^ mice are approximately 27% higher than in the plasma of the control (NCδ^+/+^) mice. And the effect is exclusive for the aldosterone synthesizing glomerulosa cells, because corticosterone (synthesized in fasciculate cells) levels are unaffected by the absence of NCδ gene.

The increased plasma aldosterone level in the NCδ^+/-^ mice correlates with the increase in blood pressure. Systolic blood pressure (measured by the non-invasive tail cuff method) was determined to be 92 ± 6 mm Hg for the wild type mice and 127 ± 9 mm Hg for the NCδ^+/-^ mice. Therefore, the conclusion of these studies was that the ANF-RGC-Ca^2+^-NCδ transduction system is not only physically present but is of physiological significance at least in the adrenal gland.

In summary, this review has high-lighted studies which define the molecular and physiological mechanisms of the hormonal signal transduction of ANF-RGC. In addition, a new signal transduction mechanism and its present state of validation has been narrated. In this model Ca^2+^ is the additional signal of ANF-RGC. By entirely different mechanism, it regulates ANF-RGC catalytic activity and controls its physiological functions.

FUTURE DIRECTIONS
=================

There are three venues through which, in these authors' understanding, the future research will progress. The first venue is centered on the basic research to decipher (1) how the ^669^WTAPELL^675^ motif "communicates" with the catalytic domain of ANF-RGC and signals its activation and (2) the mechanism of NCδ-Ca^2+^ signaling of ANF-RGC activity. The second venue relates to the physiology of both ANF-RGC signaling pathways (1) establishing whether the Ca^2+^ signaling mechanism is operative in other tissues in addition to the adrenal gland and (2) to determine the interrelationship of the hormonal and Ca^2+^ pathways. Finally, after deciphering the molecular and physiological details of the two signaling pathway the third venue will be translational, to design a molecule that can target directly the catalytic domain and bring ANF-RGC to its full activity and prevent the pandemic of hypertension, myocardial hypertrophy and obesity. The last objective is the most far-reaching, but hopefully can be achieved after the first two goals are accomplished.
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ANF

:   atrial natriuretic factor

ANF-RGC

:   atrial natriuretic factor receptor guanylate cyclase

ARM

:   ATP-regulatory module

ATP

:   adenosine triphosphate

BNP

:   B-type natriuretic peptide

CNP

:   C-type natriuretic peptide

CNP-RGC

:   C-type natriuretic peptide receptor guanylate cyclase

cyclic AMP

:   3′,5′-cyclic adenosine monophosphate

cyclic GMP

:   3′,5′-cyclic guanosine monophosphate

CNG channel

:   cyclic nucleotide gated channel

GCAP

:   guanylate cyclase activating protein

GC-A

:   guanylate cyclase-A

GC-B

:   guanylate cyclase-B

GC-C

:   guanylate cyclase-C

GC-D

:   guanylate cyclase-D

GC-E

:   guanylate cyclase-E

GC-F

:   guanylate cyclase-F

GC-G

:   guanylate cyclase-G

KHD

:   kinase homology domain

K-LD

:   kinase-like domain

NCδ

:   neurocalcin δ

NPR-A

:   natriuretic peptide receptor-A

ONE-GC

:   olfactory neuroepithelial guanylate cyclase

STa-RGC

:   heat-stable enterotoxin (also guanylin and uroguanylin) receptor guanylate cyclase

ROS-GC

:   rod outer segment guanylate cyclase
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